NY Times

DECEMBER 4, 2021

Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.

Scientist 95

Scientist Vaccination Vaccine Drugs 95

The Pharma Data

DECEMBER 4, 2021

TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of Epiduo® 1 Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the United States. Adapalene and benzoyl peroxide gel 0.3%/2.5% is a topical prescription medicine used to treat acne vulgaris.

Doctors 52

Doctors Doctor Medicine Production 52

Drug Patent Watch

DECEMBER 4, 2021

This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical drugs have the most drug patents in European Patent Office? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52

The Pharma Data

DECEMBER 4, 2021

GlaxoSmithKline (GSK) plc moment launched Target the Future, an transnational,multi-year action devoted to advancing invention and addressing crucial requirements in the multiple myeloma community. The programme will give education on progress in the field of multiple myeloma, identify crucial challenges the community faces, and grease results to help produce a better future for cases, their caregivers and loved bones.

Antibody 52

Antibody Development Drugs Scientist 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

The Pharma Data

DECEMBER 4, 2021

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF). Principal investigator Dr. Brian Grunau, Assistant Professor in UBC’s Department of Emergency Medicine and Scientist at the Centre for Health Evaluation and Outcome Sciences, indicates that these r

Immune Response 52

Immune Response Vaccination Vaccine Antibody 52

The Pharma Data

DECEMBER 4, 2021

In the first head-to-head comparison of the effectiveness of the Pfizer-BioNTech and Moderna COVID-19 vaccines, researchers examined the electronic health records of veterans who had received each vaccine. Both vaccines were highly effective in preventing COVID-19 outcomes such as documented infection, hospitalization, and death. However, the Moderna vaccine was found to offer an increased level of protection, including a 21% lower risk of documented infection and 41% lower risk of hospitalizati

Vaccination 52

Vaccination Vaccine Research Trials 52

The Pharma Data

DECEMBER 4, 2021

From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim of the study was to identify the socio-demographic factors, places visited and behaviors associated with a higher risk of infection with SARS-CoV-2.

RNA 52

RNA Vaccination Vaccine Compliance 52